as on October 29, 2025 at 8:04 pm IST
Day's Low
Day's High
1.89%
Downside
1.89%
Upside
52 Week's Low
52 Week's High
82.16%
Downside
15.78%
Upside
Check Atai Life Sciences Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
-0.5175
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.97%
PE Ratio (TTM)
-3.76
Industry PE ratio
-0.8809294871794872
PEG Ratio
0EBITDA
-94.8M
Revenue (TTM)
2.3M
Profit Margin
0.00%
Return On Equity TTM
-76.50%
Track how Atai Life Sciences Nv P/E has moved over time to understand its valuation trends.
Atai Life Sciences Nv in the last 5 years
Lowest (-23.76x)
June 30, 2021
Today (-3.76x)
October 29, 2025
Industry (-0.88x)
October 29, 2025
Highest (-1.43x)
December 31, 2024
Today’s Price to Earnings Ratio: -3.76x
Compare market cap, revenue, PE, and other key metrics of Atai Life Sciences Nv with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.7B | NA | -3.76 | 0.00% | |
| BUY | $62.7B | 285.91% | -505.15 | -12.96% | |
| NA | $36.5B | NA | NA | -3.89% | |
| BUY | $108.0B | 104.04% | 29.95 | 31.86% | |
| BUY | $62.0B | 17.76% | 14.75 | 31.37% |
The Atai Life Sciences Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atai Life Sciences Nv investment value today
Current value as on today
₹5,16,465
Returns
₹4,16,465
(+416.46%)
Returns from Atai Life Sciences Nv Stock
₹4,11,404 (+411.4%)
Dollar Returns*
₹5,061 (+5.06%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Atai Life Sciences Nv. Average target price of $12.11
Get share price movements and forecasts by analysts on Atai Life Sciences Nv.
What analysts predicted
51.86%UPSIDE
Target Price
$12.11
Current Price
$5.83
Analyzed by
13 Analysts
Target
$12.11
Atai Life Sciences Nv target price $12.11, a slight upside of 51.86% compared to current price of $5.83. According to 13 analysts rating.
Investment in Atai Life Sciences Nv Shares on INDmoney has grown by 126.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:126.00% versus previous 30 day period
Search interest for Atai Life Sciences Nv Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:16% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, ATAI has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 months, ATAI stock has moved up by 80.1%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.7% return, outperforming this stock by 34.0%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.55M → 719.0K (in $), with an average decrease of 53.8% per quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, -26.43M → -27.72M (in $), with an average decrease of 4.9% per quarter
| Organisation | Atai Life Sciences Nv |
| Headquarters | Prof. J.H. Bavincklaan 7, Amstelveen, Netherlands, 1183 AT |
| Industry | Commercial Services |
| CEO | Dr. Srinivas G. Rao M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Anne Johnson | Chief Financial Officer |
Dr. Gerd G. Kochendoerfer Ph.D. | Chief Operating Officer |
Dr. Glenn Short Ph.D. | Chief Scientific Officer |
Mr. Ryan Barrett J.D. | General Counsel & Corporate Secretary |
Dr. Kevin Craig M.D. | Chief Medical Officer |
Mr. Christian Angermayer | Co-Founder & Chairman of the Supervisory Board |
Dr. Srinivas G. Rao M.D., Ph.D. | Co-Founder, CEO & Executive Director |
Atai Life Sciences Nv share price today is $5.83 as on . Atai Life Sciences Nv share today touched a day high of $5.94 and a low of $5.72.
Atai Life Sciences Nv share touched a 52 week high of $6.75 on and a 52 week low of $1.04 on . Atai Life Sciences Nv stock price today i.e. is trending at $5.83,which is 13.63% down from its 52 week high and 460.58% up from its 52 week low.
Atai Life Sciences Nv market capitalisation is $0.00T as on .
Indian investors can start investing in Atai Life Sciences Nv (ATAI) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Atai Life Sciences Nv stock (as per the Rupee-Dollar exchange rate as on ).
Based on Atai Life Sciences Nv share’s latest price of $5.83 as on October 29, 2025 at 8:04 pm IST, you will get 1.7153 shares of Atai Life Sciences Nv. Learn more about
fractional shares .